New Hope For Those With Alzheimer's

For decades, Alzheimer’s disease has been treated as one of medicine’s most frustrating mysteries. Billions of dollars have been spent trying to remove the amyloid plaques that accumulate in the brains of Alzheimer’s patients. Yet despite enormous effort, the results have been disappointing. In fact, the overwhelming majority of Alzheimer’s drug trials—more than 99 percent—have failed to produce meaningful results.

But a new line of research is challenging the assumptions that have guided Alzheimer’s science for years.

Instead of focusing primarily on plaques, researchers are now looking at something deeper: the brain’s energy system.

A recently published study highlighted in the video below suggests that Alzheimer’s disease may be closely linked to a breakdown in the brain’s energy metabolism. At the centre of this discovery is a molecule called NAD (nicotinamide adenine dinucleotide), a compound present in every cell of the body and essential for producing cellular energy. When NAD levels fall, cells struggle to generate the energy they need to function properly.

And that may be particularly dangerous in the brain.

The Alzheimer’s Paradox

One of the longstanding puzzles in Alzheimer’s research is that many people have large amounts of amyloid plaque in their brains yet remain cognitively normal. In fact, studies suggest that as many as 20–50% of people with significant plaque show no dementia symptoms at all.

Why?

The new research points to NAD as a possible explanation. People whose brains maintain higher NAD levels appear to be more resilient, continuing to think clearly even when typical Alzheimer’s pathology is present.

Remarkable Results in the Laboratory

To test this theory, scientists conducted experiments using established mouse models of Alzheimer’s disease. As the disease progressed in these animals, their NAD levels steadily declined. But when researchers used a compound that boosts NAD production, the results were striking.

According to the study:

• Memory deficits were prevented and even reversed

• Learning ability improved

• Brain inflammation dropped

• The integrity of the blood-brain barrier improved

• Key markers of Alzheimer’s pathology were reduced

Even more surprising, these improvements occurred even when treatment was started at later stages of the disease, challenging the long-held belief that Alzheimer’s is inevitably progressive and irreversible.

What About Humans?

While animal studies don’t always translate directly to people, the researchers also examined human brain data. They found a similar pattern: individuals with Alzheimer’s disease tend to have significantly disrupted NAD metabolism, with lower production and higher breakdown of this key molecule.

In contrast, individuals with high plaque levels but normal cognition tended to maintain higher NAD levels, strengthening the idea that NAD may act as a kind of metabolic shield for the brain.

A New Direction in Alzheimer’s Prevention

Perhaps the most encouraging aspect of this research is that it points toward practical strategies that may help support healthy NAD levels. These include lifestyle factors already associated with good metabolic health, such as:

• Regular physical exercise

• Maintaining muscle mass and cardiovascular fitness

• Intermittent fasting or ketogenic metabolic states

• Reducing chronic inflammation

• Maintaining good sleep and nutrition

None of these are silver bullets. Alzheimer’s is a complex disease. But this research suggests we may have been focusing too narrowly on plaques while overlooking a more fundamental issue: the brain’s energy supply.

If these findings continue to hold up, they could open an entirely new frontier in Alzheimer’s prevention and treatment—one focused not simply on removing damage, but on restoring the brain’s metabolic resilience.

That’s a hopeful shift.

The video below explains this fascinating research in more detail.

VV